Cargando…
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism
Glioblastoma (GBM) is the most common and aggressive primary brain tumor, but the mechanisms underlying tumor growth and progression remain unclear. The protein arginine methyltransferases (PRMTs) regulate a variety of biological processes, however, their roles in GBM growth and progression are not...
Autores principales: | Liao, Yunfei, Luo, Zaili, Lin, Yifeng, Chen, Huiyao, Chen, Tong, Xu, Lingli, Orgurek, Sean, Berry, Kalen, Dzieciatkowska, Monika, Reisz, Julie A., D’Alessandro, Angelo, Zhou, Wenhao, Lu, Q. Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646854/ https://www.ncbi.nlm.nih.gov/pubmed/36351894 http://dx.doi.org/10.1038/s41419-022-05389-1 |
Ejemplares similares
-
Genomic and Transcriptomic Analyses Reveals ZNF124 as a Critical Regulator in Highly Aggressive Medulloblastomas
por: Luo, Zaili, et al.
Publicado: (2021) -
PRMT5 inhibition disrupts splicing and stemness in glioblastoma
por: Sachamitr, Patty, et al.
Publicado: (2021) -
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
por: Zhang, Xin, et al.
Publicado: (2021) -
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
por: Miska, Jason, et al.
Publicado: (2019) -
MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma
por: Alfardus, Huda, et al.
Publicado: (2017)